Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept

Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept

Background Anti-vascular endothelial growth factor agents have now become the first line of treatment for diabetic macular edema (DME). Changes in the thickness of the individual retinal layers including the ganglion cell–inner plexiform layer (GC–IPL) might serve as a biomarker for the response to...

Full description

Saved in:
Bibliographic Details
Main Authors: Mouna M. Alsaad, Amin B. Shehadeh, Iyman M. Alsaad, Khalid A. Alubous, Jehad S. Meqbil, Mohammed Z. Qablawi, Saif Aldeen S. AIRyalat, Rawan A. Elubous
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Delta Journal of Ophthalmology
Subjects:
aflibercept
anti-vascular endothelial growth factor
diabetic macular edema
ganglion cell–inner plexiform layer
retinal thickness
visual acuity
Online Access:https://journals.lww.com/10.4103/djo.djo_51_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items